Stephenson AJ, Slawin KM: The value of radiotherapy in treating recurrent prostate cancer after radical prostatectomy. MATERIALS AND METHODS: We reviewed the records of 2,042 patients who underwent radical prostatectomy of prostate cancer between 1998 and 2013. Radiation therapy (RT) following radical prostatectomy (RP) for high-risk localized prostate cancer offers no advantage in terms of biochemical recurrence compared with … J Clin Oncol 24:: 3973, 2006-3978, Link, Google Scholar: 28. (ABSTRACT TRUNCATED AT 400 WORDS) In this series patients undergoing radical prostatectomy for clinically localized prostate cancer were usually healthy and, thus, had low co-morbidity. Your doctor will be able to … It also cures most patients, even in cases where cancer has reached or penetrated the prostate wall, the tumor cells are well-differentiated (with a Gleason score of 6 or lower), or surgeons are able to remove all cancer cells (confirmed by clear or negative surgical margins). Stephenson AJ, Kattan MW, Eastham JA, et al: Defining biochemical recurrence of prostate cancer after radical prostatectomy: A proposal for a standardized definition. The figures below, provided by the American Cancer Society, represent the average relative survival rate of all men with prostate cancer. We evaluated the conditional probability of biochemical recurrence (BCR)-free survival (C-BCRFS) after radical prostatectomy (RP) for prostate cancer according to the National Comprehensive Cancer … Radical prostatectomy cures the vast majority of patients with cancer confined to the prostate. Survival rates at 10 and 15 years compare favorably with those of an age-matched control group. For prostate cancer that has spread to distant areas of the body, the five-year relative survival rate is about 29 percent. They represent a patient’s chances of survival after a specified number of years as compared with the larger population’s chances of survival during that same timeframe. We retrospectively investigated the association of muscle mass with survival after radical prostatectomy in patients with prostate cancer. Most analyses of conditional survival in prostate cancer are not clinically applicable because they do not analyze outcomes conditioned on the durability of cure after treatment.